Showing 34,867 articles by Roger Pebody

Filters Author: Roger Pebody

Roger joined NAM in 2008 as an Editor and became Managing Editor in 2018. He is responsible for co-ordinating the editorial content of aidsmap.com, including news coverage and patient information materials. His involvement in HIV work began at Gay Men Fighting AIDS in the mid-1990s. Twitter: @RogerPebody

Treatment outcomes & life expectancy

Doubled Risk of non-HIV Mortality in US People at Risk for HIV

Editor's pick
NATAP
20 March 2020
Cancer

Low Adherence to Treatment and Follow-up of Anal Cancer Precursor

Editor's pick
NATAP
20 March 2020
Coronavirus

EACS & BHIVA Statement on risk of COVID-19 for people living with HIV

Editor's pick
European AIDS Clinical Society
20 March 2020
Coronavirus

Patient Risk for COVID-19 Uncertain in Some Specialties

Editor's pick
MedPage Today
20 March 2020
Epidemiology & behaviour

Africans with disabilities are at higher risk of HIV

Editor's pick
The Economist
20 March 2020
Coronavirus

No Benefit to HIV Medication for COVID-19 Infection

Editor's pick
MedPage Today
19 March 2020
Coronavirus

Coronavirus (COVID-19) and HIV - Questions and Answers

Editor's pick
BHIVA
19 March 2020
Retention & linkage to care

Adherence clubs linked to 30% reduction in high viral load among postpartum South African women living with HIV

News
19 March 2020
Coronavirus

Lopinavir/ritonavir does not relieve severe Covid-19

Editor's pick
New England Journal of Medicine
19 March 2020
Coronavirus

Coronavirus disease (COVID-19), HIV and hepatitis C: What you need to know

Editor's pick
CATIE
18 March 2020

CROI 2020: Las madres recientes con el VIH ganan más peso con dolutegravir que con efavirenz, 18 de marzo de 2020

March 2020
TB transmission & prevention

Single round of 3HP safe, effective for PLWH on ART

Editor's pick
Healio
18 March 2020
Global health targets

Special investigation: Claims of 90-90-90 success in KwaZulu Natal districts were premature

Editor's pick
Spotlight
18 March 2020

CROI 2020: Les nouvelles mères séropositives prennent plus de poids avec le dolutégravir qu'avec l'efavirenz, 18 mars 2020

March 2020
The search for a cure

Halting Start for Kick & Kill, CROI Previews New HIV Cure Approaches on the Horizon

Editor's pick
Treatment Action Group
18 March 2020
Weight gain & lipodystrophy

Weight gain after starting HIV treatment may have genetic influences

News
18 March 2020
Liver disease

HIV-positive people with fatty liver disease are at high risk for fibrosis

News
18 March 2020

CROI 2020: Dolutegravir associato a maggior aumento di peso post-parto rispetto all’efavirenz, 18 marzo 2020

March 2020

КРОИ 2020: ВИЧ-инфицированные роженицы прибавляют в весе больше при приеме долутегравира, чем эфавиренц, 18 марта 2020

March 2020

CROI 2020: New mothers with HIV gain more weight on dolutegravir than efavirenz, 18 March 2020

March 2020

CROI 2020: Mulheres com VIH que foram mães recentemente ganham mais peso com dolutegravir do que com efavirenz, 18 de março de 2020

March 2020
The search for a cure

Child with HIV maintains viral suppression for three years off treatment

News
18 March 2020
PrEP science

Diagnostic challenges with PrEP use during early HIV infection

News
18 March 2020
HIV treatment for children & young people

New approaches for paediatric dosing: abacavir in newborns, doubling dolutegravir with rifampicin

News
18 March 2020